CKD 5
The percentage of patients on the CKD register with hypertension and proteinuria who are treated with an angiotensin coverting enzyme inhibitor (ACE-I) or angiotensin receptor blocker (AEB) (unless a contraindication or side effects are recorded)
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| CKD 5 | 2011 | 293 | 319 | 91.8% | |
| CKD 5 | 2012 | 301 | 340 | 88.5% | |
| CKD 5 | 2013 | 326 | 364 | 89.6% | |
| CKD003 | 2014 | 320 | 348 | 92.0% | |
| CKD003 | 2015 | 296 | 317 | 93.4% | |
| NM84 | 2016 | 285 | 364 | 78.3% | |
| NM84 | 2017 | 245 | 334 | 73.4% | |
| NM84 | 2018 | 592 | 793 | 74.7% | |
| NM84 | 2023 | 282 | 375 | 75.2% |
